Leap Therapeutics
LPTX | NASDAQ
$0.77
-$0.02 (-3.10%)
At close: Apr 01, 2026, 09:30 AM ET
Leap Therapeutics Company Profile
Company profile explainedCompany Profile
Leap Therapeutics, Inc. is a biopharmaceutical firm dedicated to discovering and advancing treatments for various cancers. At the forefront of its pipeline is DKN-01, a monoclonal antibody designed to block Dickkopf-related protein 1 (DKK1). This investigational therapy is currently undergoing several clinical trials, targeting a range of malignancies such as esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap Therapeutics has also forged an option and licensing partnership with BeiGene, Ltd., granting them rights to develop and market DKN-01 across Asia (excluding Japan), Australia, and New Zealand. Established in 2011, the company initially operated as HealthCare Pharmaceuticals, Inc., before rebranding to Leap Therapeutics, Inc. in November 2015. Its corporate headquarters are situated in Cambridge, Massachusetts.
Key Executives
| Name | Position |
|---|---|
| Douglas E. Onsi | Chief Financial Officer, General Counsel, Treasurer & Secretary, President, Chief Executive Officer & Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 25, 2026 | 3 | Filing |
| Sep 25, 2026 | 4 | Filing |
| Sep 25, 2026 | 4 | Filing |
| Sep 22, 2026 | 8-K | Current Report |
| Sep 02, 2026 | 8-K | Current Report |
| Aug 27, 2026 | 4 | Filing |
| Aug 26, 2026 | 144 | Filing |
| Aug 24, 2026 | 4 | Filing |
| Aug 24, 2026 | 3 | Filing |
| Aug 19, 2026 | 4 | Filing |
Leap Therapeutics
| Country | United States |
| IPO Date | Jan 25, 2017 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 52 |
| CEO | Douglas E. Onsi |
Contact Details
47 Thorndike Street Cambridge,
Massachusetts 02141 United States
Stock Details
| Ticker Symbol | LPTX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001509745 |
| CUSIP Number | 52187K200 |
| ISIN Number | US52187K2006 |
| SIC Code | 2834 |
Add to Watchlist
Select watchlists to add or remove LPTX